Combined formulations containing a liraglutide nanoformulation and an SGLT-2 inhibitor have been shown to significantly improve blood lipid profiles in patients with type 2 diabetes
When youre working with providers who specialize in obesity management, they are going to be able to help meet you where you are, says Cassetty
Reported effects Supports increases in lean muscle mass Enhances fat metabolism and improves body composition Aids in recovery and tissue repair Highly selective for GH release with minimal side effects on other hormones May improve gastric motility and digestive function Reported side effects Occasional mild injection-site reactions (redness, swelling) Very rare reports of water retention Very rare reports of increased hunger Storage Lyophilised (unmixed) 2-8 C (35.6-46.4 F) or freeze at -20 C (-4 F) in dry, dark conditions After reconstitution Refrigerate at 2-8 C (35.6-46.4 F) and use within ~4 weeks

doi: 10.3389/fphar.2023.1182788 Received 09 March 2023 Accepted 31 March 2023 Published 06 April 2023 Volume 14 - 2023 Edited by Xuelin Zhou, Capital Medical University, China Reviewed by Yachen Shen, University of Pennsylvania, United States Yusheng Li, University of Mississippi, United States Shengjie Xu, Merck, United States Changlu Xu, University of California, Los Angeles, United States Updates Copyright 2023 Jing, Iba, Naito, Xu, Morishige, Nagata, Okubo and Ando